Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1987 Jun;84(11):3916–3920. doi: 10.1073/pnas.84.11.3916

Use of 2-[125I]iodomelatonin to characterize melatonin binding sites in chicken retina.

M L Dubocovich, J S Takahashi
PMCID: PMC304987  PMID: 3035559

Abstract

2-[125I]Iodomelatonin binds with high affinity to a site possessing the pharmacological characteristics of a melatonin receptor in chicken retinal membranes. The specific binding of 2-[125I]iodomelatonin is stable, saturable, and reversible. Saturation experiments indicated that 2-[125I]iodomelatonin labeled a single class of sites with an affinity constant (Kd) of 434 +/- 56 pM and a total number of binding sites (Bmax) of 74.0 +/- 13.6 fmol/mg of protein. The affinity constant obtained from kinetic analysis was in close agreement with that obtained in saturation experiments. Competition experiments showed a monophasic reduction of 2-[125I]iodomelatonin binding with a pharmacological order of indole amine affinities characteristic of a melatonin receptor: 2-iodomelatonin greater than 6-chloromelatonin greater than or equal to melatonin greater than or equal to 6,7-dichloro-2-methylmelatonin greater than 6-hydroxymelatonin greater than or equal to 6-methoxymelatonin much greater than N-acetyltryptamine greater than N-acetyl-5-hydroxytryptamine greater than 5-methoxytryptamine greater than 5-hydroxytryptamine (inactive). The affinities of these melatonin analogs in competing for 2-[125I]iodomelatonin binding sites were correlated closely with their potencies for inhibition of the calcium-dependent release of [3H]dopamine from chicken and rabbit retinas, indicating association of the binding site with a functional response regulated by melatonin. The results indicate that 2-[125I]iodomelatonin is a selective, high-affinity radioligand for the identification and characterization of melatonin receptor sites.

Full text

PDF
3916

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Besharse J. C., Dunis D. A. Methoxyindoles and photoreceptor metabolism: activation of rod shedding. Science. 1983 Mar 18;219(4590):1341–1343. doi: 10.1126/science.6828862. [DOI] [PubMed] [Google Scholar]
  2. Cardinali D. P., Vacas M. I., Boyer E. E. Specific binding of melatonin in bovine brain. Endocrinology. 1979 Aug;105(2):437–441. doi: 10.1210/endo-105-2-437. [DOI] [PubMed] [Google Scholar]
  3. Cheng Y., Prusoff W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973 Dec 1;22(23):3099–3108. doi: 10.1016/0006-2952(73)90196-2. [DOI] [PubMed] [Google Scholar]
  4. Dubocovich M. L. Characterization of a retinal melatonin receptor. J Pharmacol Exp Ther. 1985 Aug;234(2):395–401. [PubMed] [Google Scholar]
  5. Dubocovich M. L., Lucas R. C., Takahashi J. S. Light-dependent regulation of dopamine receptors in mammalian retina. Brain Res. 1985 Jun 3;335(2):321–325. doi: 10.1016/0006-8993(85)90485-8. [DOI] [PubMed] [Google Scholar]
  6. Dubocovich M. L. Melatonin is a potent modulator of dopamine release in the retina. Nature. 1983 Dec 22;306(5945):782–784. doi: 10.1038/306782a0. [DOI] [PubMed] [Google Scholar]
  7. Dubocovich M. L. N-Acetyltryptamine antagonizes the melatonin-induced inhibition of [3H]dopamine release from retina. Eur J Pharmacol. 1984 Oct 1;105(1-2):193–194. doi: 10.1016/0014-2999(84)90668-x. [DOI] [PubMed] [Google Scholar]
  8. Dubocovich M. L., Weiner N. Modulation of the stimulation-evoked release of [3H]dopamine in the rabbit retina. J Pharmacol Exp Ther. 1981 Dec;219(3):701–707. [PubMed] [Google Scholar]
  9. Glass J. D., Lynch G. R. Melatonin: identification of sites of antigonadal action in mouse brain. Science. 1981 Nov 13;214(4522):821–823. doi: 10.1126/science.7292016. [DOI] [PubMed] [Google Scholar]
  10. Hamm H. E., Menaker M. Retinal rhythms in chicks: circadian variation in melantonin and serotonin N-acetyltransferase activity. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4998–5002. doi: 10.1073/pnas.77.8.4998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. McPherson G. A. A practical computer-based approach to the analysis of radioligand binding experiments. Comput Programs Biomed. 1983 Aug-Oct;17(1-2):107–113. doi: 10.1016/0010-468x(83)90031-4. [DOI] [PubMed] [Google Scholar]
  12. Niles L. P., Wong Y. W., Mishra R. K., Brown G. M. Melatonin receptors in brain. Eur J Pharmacol. 1979 Apr 15;55(2):219–220. doi: 10.1016/0014-2999(79)90397-2. [DOI] [PubMed] [Google Scholar]
  13. Ogino N., Matsumura M., Shirakawa H., Tsukahara I. Phagocytic activity of cultured retinal pigment epithelial cells from chick embryo: inhibition by melatonin and cyclic AMP, and its reversal by taurine and cyclic GMP. Ophthalmic Res. 1983;15(2):72–89. doi: 10.1159/000265239. [DOI] [PubMed] [Google Scholar]
  14. Pang S. F., Yew D. T. Pigment aggregation by melatonin in the retinal pigment epithelium and choroid of guinea-pigs, Caviaporcellus. Experientia. 1979 Feb 15;35(2):231–233. doi: 10.1007/BF01920634. [DOI] [PubMed] [Google Scholar]
  15. Pierce M. E., Besharse J. C. Circadian regulation of retinomotor movements. I. Interaction of melatonin and dopamine in the control of cone length. J Gen Physiol. 1985 Nov;86(5):671–689. doi: 10.1085/jgp.86.5.671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Reiter R. J., Richardson B. A., Matthews S. A., Lane S. J., Ferguson B. N. Rhythms in immunoreactive melatonin in the retina and Harderian gland of rats: persistence after pinealectomy. Life Sci. 1983 Mar 14;32(11):1229–1236. doi: 10.1016/0024-3205(83)90192-3. [DOI] [PubMed] [Google Scholar]
  17. Underwood H., Harless M. Entrainment of the circadian activity rhythm of a lizard to melatonin injections. Physiol Behav. 1985 Aug;35(2):267–270. doi: 10.1016/0031-9384(85)90348-8. [DOI] [PubMed] [Google Scholar]
  18. Vacas M. I., Cardinali D. P. Binding sites for melatonin in bovine pineal gland. Horm Res. 1980;13(2):121–131. doi: 10.1159/000179278. [DOI] [PubMed] [Google Scholar]
  19. Vakkuri O., Leppäluoto J., Vuolteenaho O. Development and validation of a melatonin radioimmunoassay using radioiodinated melatonin as tracer. Acta Endocrinol (Copenh) 1984 Jun;106(2):152–157. doi: 10.1530/acta.0.1060152. [DOI] [PubMed] [Google Scholar]
  20. Vakkuri O., Lämsä E., Rahkamaa E., Ruotsalainen H., Leppäluoto J. Iodinated melatonin: preparation and characterization of the molecular structure by mass and 1H NMR spectroscopy. Anal Biochem. 1984 Nov 1;142(2):284–289. doi: 10.1016/0003-2697(84)90466-4. [DOI] [PubMed] [Google Scholar]
  21. Wiechmann A. F., Bok D., Horwitz J. Melatonin-binding in the frog retina: autoradiographic and biochemical analysis. Invest Ophthalmol Vis Sci. 1986 Feb;27(2):153–163. [PubMed] [Google Scholar]
  22. Yu H. S., Pang S. F., Tang P. L. Increase in the level of retinal melatonin and persistence of its diurnal rhythm in rats after pinealectomy. J Endocrinol. 1981 Dec;91(3):477–481. doi: 10.1677/joe.0.0910477. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES